Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D Postle

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Respiratory Physiology & Neurobiology|March 9, 2010
Recent advances in alveolar biology: some new looks at the alveolar interfaceFred Possmayer, Stephen B Hall, Thomas Haller, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 2, 2010
Conditional deletion of Abca3 in alveolar type II cells alters surfactant homeostasis in newborn and adult miceValérie Besnard, Yohei Matsuzaki, Jean Clark, et al.
Journal of Lipid Research|August 16, 2018
Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult miceJens Madsen, Madhuriben H Panchal, Rose-Marie A Mackay, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|February 11, 2026
Surfactant nebulization in severe COVID-19: Tracheal aspirate phospholipid turnover and metabolismAnthony D Postle, Howard W Clark, James Fink, et al.
Clinical Science (London, England : 1979)|November 15, 2021
Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnoverDominic J Corkill, Alan N Hunt, Mary Jane Hinrichs, et al.
Scientific Reports|November 28, 2023
A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)Ahilanandan Dushianthan, Howard W Clark, David Brealey, et al.
Cells|April 30, 2021
Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA MouseTamara L Paget, Emma J Parkinson-Lawrence, Paul J Trim, et al.
Tissue Barriers|January 5, 2024
Membrane lipid composition of bronchial epithelial cells influences antiviral responses during rhinovirus infectionMadhuriben H Panchal, Emily J Swindle, Theresa J Pell, et al.
The International Journal of Biochemistry & Cell Biology|June 26, 2012
Lipidomic profiling in Crohn's disease: abnormalities in phosphatidylinositols, with preservation of ceramide, phosphatidylcholine and phosphatidylserine compositionGavin W Sewell, Yusuf A Hannun, Xianlin Han, et al.
The ISME Journal|November 14, 2015
Lipid remodelling is a widespread strategy in marine heterotrophic bacteria upon phosphorus deficiencyMarta Sebastián, Alastair F Smith, José M González, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Respiratory Physiology & Neurobiology|March 9, 2010
Recent advances in alveolar biology: some new looks at the alveolar interfaceFred Possmayer, Stephen B Hall, Thomas Haller, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 2, 2010
Conditional deletion of Abca3 in alveolar type II cells alters surfactant homeostasis in newborn and adult miceValérie Besnard, Yohei Matsuzaki, Jean Clark, et al.
Journal of Lipid Research|August 16, 2018
Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult miceJens Madsen, Madhuriben H Panchal, Rose-Marie A Mackay, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|February 11, 2026
Surfactant nebulization in severe COVID-19: Tracheal aspirate phospholipid turnover and metabolismAnthony D Postle, Howard W Clark, James Fink, et al.
Clinical Science (London, England : 1979)|November 15, 2021
Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnoverDominic J Corkill, Alan N Hunt, Mary Jane Hinrichs, et al.
Scientific Reports|November 28, 2023
A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)Ahilanandan Dushianthan, Howard W Clark, David Brealey, et al.
Cells|April 30, 2021
Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA MouseTamara L Paget, Emma J Parkinson-Lawrence, Paul J Trim, et al.
Tissue Barriers|January 5, 2024
Membrane lipid composition of bronchial epithelial cells influences antiviral responses during rhinovirus infectionMadhuriben H Panchal, Emily J Swindle, Theresa J Pell, et al.
The International Journal of Biochemistry & Cell Biology|June 26, 2012
Lipidomic profiling in Crohn's disease: abnormalities in phosphatidylinositols, with preservation of ceramide, phosphatidylcholine and phosphatidylserine compositionGavin W Sewell, Yusuf A Hannun, Xianlin Han, et al.
The ISME Journal|November 14, 2015
Lipid remodelling is a widespread strategy in marine heterotrophic bacteria upon phosphorus deficiencyMarta Sebastián, Alastair F Smith, José M González, et al.
Pageof 8